Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Precursor Cell Lymphoblastic Leukemia-Lymphoma"" wg kryterium: Temat


Tytuł:
Glycolysis Modulation by METTL7B Shapes Acute Lymphoblastic Leukemia Cell Proliferation and Chemotherapy Response.
Autorzy:
Zhang L; Department of Human Anatomy, School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong, China.
Liu X; Department of Hematology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Zhou S; Department of Human Anatomy, School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong, China.
Wang P; Department of Critical Care Unit, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhang X; Department of Geriatric Respiratory Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. .
Pokaż więcej
Źródło:
Human cell [Hum Cell] 2024 Mar; Vol. 37 (2), pp. 478-490. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Humans ; Glycolysis/genetics ; Cell Proliferation/genetics ; Methyltransferases/genetics ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Fatal tumor lysis syndrome in a pediatric patient with acute lymphoblastic leukemia treated with venetoclax.
Autorzy:
Trinder SM; Department of Haematology, Oncology and Bone Marrow Transplant, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Soggee J; Pharmacy Department, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Spragg J; Department of Haematology, Oncology and Bone Marrow Transplant, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Alexander D; Department of Paediatric Critical Care, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Mitchell R; Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine & Health, University of New South Wales, Kensington, New South Wales, Australia.
Gottardo NG; Department of Haematology, Oncology and Bone Marrow Transplant, Perth Children's Hospital, Nedlands, Western Australia, Australia.
Ramachandran S; Department of Haematology, Oncology and Bone Marrow Transplant, Perth Children's Hospital, Nedlands, Western Australia, Australia.; School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Mar; Vol. 71 (3), pp. e30841. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Letter
MeSH Terms:
Tumor Lysis Syndrome*/etiology
Tumor Lysis Syndrome*/pathology
Antineoplastic Agents*/adverse effects
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Sulfonamides*
Humans ; Child ; Bridged Bicyclo Compounds, Heterocyclic/adverse effects
Opinia redakcyjna
Tytuł:
Missing the mark? Exploratory analysis of the 10-year-old cutoff as an independent marker of high-risk disease in pediatric B-ALL.
Autorzy:
George PE; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
DeGroote NP; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Henderson M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Jordan K; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Ziworitin-Ogola C; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Castellino SM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Miller TP; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Mar; Vol. 71 (3), pp. e30825. Date of Electronic Publication: 2023 Dec 25.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Child ; Humans ; Retrospective Studies ; Risk Factors ; Prognosis ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study.
Autorzy:
Ashouri K; Keck School of Medicine, University of Southern California, Los Angeles, CA.
Nittur V; Keck School of Medicine, University of Southern California, Los Angeles, CA.
Ginosyan AA; Keck School of Medicine, University of Southern California, Los Angeles, CA.
Hwang J; Keck School of Medicine, University of Southern California, Los Angeles, CA.
Adnani B; Keck School of Medicine, University of Southern California, Los Angeles, CA.
Chen D; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Savitala-Damerla L; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Schiff K; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Chaudhary P; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Kovach AE; Keck School of Medicine, University of Southern California, Los Angeles, CA; Hematopathology, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA.
Ladha A; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Siddiqi I; Keck School of Medicine, University of Southern California, Los Angeles, CA; Division of Pathology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Ali A; Department of Pharmacy, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Woan K; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Tam E; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA.
Yaghmour G; Jane Anne Nohl Division of Hematology and Center for the study of Blood disease, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA. Electronic address: .
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. e59-e66.e2. Date of Electronic Publication: 2023 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Hematopoietic Stem Cell Transplantation*/methods
Adult ; Humans ; Retrospective Studies ; Flow Cytometry ; Acute Disease ; Recurrence ; Neoplasm, Residual/diagnosis ; Neoplasm, Residual/therapy ; High-Throughput Nucleotide Sequencing/methods
Czasopismo naukowe
Tytuł:
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Autorzy:
Ishida H; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
Arakawa Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Hasegawa D; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Usami I; Department of Pediatric Hematology and Oncology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
Hashii Y; Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan.
Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nishiwaki S; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Keino D; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Kato K; Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Ibaraki, Japan.
Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan.
Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
Okada K; Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan.
Hidaka M; Department of Pediatrics, The University of Tokyo Hospital, Tokyo, Japan.
Yuza Y; Department of Hematology/Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Watanabe K; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
Takita J; Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan.
Kosaka Y; Department of Hematology and Oncology, Center of Childhood Cancer, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Fujita N; Department of Pediatrics, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465, Kajiichou, Hirokouji Kawaramachidori, Kamigyo-ku, Kyoto, 602-8566, Japan. .
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 843-854. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Child ; Humans ; Adolescent ; Retrospective Studies ; Philadelphia Chromosome ; Acute Disease ; Transplantation Conditioning
Czasopismo naukowe
Tytuł:
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia.
Autorzy:
Lee BJ; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California, USA.
Griffin SP; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California, USA.
Doh J; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Chan A; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California, USA.; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Ciurea SO; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Jeyakumar D; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Fleischman AG; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Naqvi K; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Pannunzio NR; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
O'Brien S; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Kongtim P; Department of Medicine, Division of Hematology Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 392-401. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/epidemiology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Young Adult ; Humans ; Male ; Adult ; Asparaginase/adverse effects ; Polyethylene Glycols/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Fusarium oxysporum disseminated infection in a teenage patient with a relapse of acute lymphoblastic leukemia - Case report and review of the literature.
Autorzy:
Samborska M; Department of Pediatric Oncology, Hematology and Transplantology, Poznań, Poland; University of Medical Sciences, Poznań, Poland. Electronic address: .
Wziątek A; Department of Pediatric Oncology, Hematology and Transplantology, Poznań, Poland; University of Medical Sciences, Poznań, Poland.
Młynarczyk Ł; Department of Pediatric Oncology, Hematology and Transplantology, Poznań, Poland; University of Medical Sciences, Poznań, Poland.
Dey S; Department of Pediatric Oncology, Hematology and Transplantology, Poznań, Poland; University of Medical Sciences, Poznań, Poland.
Varghese N; Department of Pediatric Oncology, Hematology and Transplantology, Poznań, Poland; University of Medical Sciences, Poznań, Poland.
Derwich K; Department of Pediatric Oncology, Hematology and Transplantology, Poznań, Poland; University of Medical Sciences, Poznań, Poland.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Mar; Vol. 30 (3), pp. 258-262. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Review; Case Reports
MeSH Terms:
Fusarium*
Fusariosis*/diagnosis
Fusariosis*/drug therapy
Fusariosis*/microbiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Adolescent ; Child ; Humans ; Antifungal Agents/therapeutic use ; Recurrence
SCR Organism:
Fusarium oxysporum
Recenzja
Tytuł:
SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia.
Autorzy:
Shimony S; Dana-Farber Cancer Institute, Boston, MA; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Luskin MR; Dana-Farber Cancer Institute, Boston, MA. Electronic address: marlise_.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. 133-140. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Antibodies, Bispecific*
Bridged Bicyclo Compounds, Heterocyclic*
Humans ; Aged ; Inotuzumab Ozogamicin/therapeutic use ; Sulfonamides/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Tytuł:
A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
Autorzy:
Gupta DG; Department of Urology & Pathology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Varma N; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Abdulkadir SA; Department of Urology & Pathology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Sreedharanunni S; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sachdeva MUS; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Naseem S; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Bose P; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Binota J; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Malhotra P; Department of Clinical Hematology & Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Khadwal A; Department of Clinical Hematology & Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Trehan A; Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Varma S; Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło:
Cancer [Cancer] 2024 Mar 01; Vol. 130 (5), pp. 713-726. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Humans ; Male ; Philadelphia Chromosome ; In Situ Hybridization, Fluorescence ; Neoplasm, Residual ; Acute Disease
Czasopismo naukowe
Tytuł:
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
Autorzy:
Tsilingiris D; First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Dragana, 68100, Alexandroupolis, Greece.
Vallianou NG; Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou str, 10676, Athens, Greece.
Spyrou N; Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, 1190 One Gustave L. Levy Place, New York, NY, 10029, USA.
Kounatidis D; Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou str, 10676, Athens, Greece.
Christodoulatos GS; Department of Microbiology, Sismanogleio General Hospital, 1 Sismanogleiou Str, 15126, Athens, Greece.
Karampela I; 2nd Department of Critical Care, Medical School, University of Athens, Attikon General University Hospital, 1 Rimini Str, 12462, Athens, Greece.
Dalamaga M; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias str, 11527, Athens, Greece. .
Pokaż więcej
Źródło:
Current obesity reports [Curr Obes Rep] 2024 Mar; Vol. 13 (1), pp. 1-34. Date of Electronic Publication: 2023 Dec 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pandemics*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Child ; Humans ; Obesity/complications ; Obesity/epidemiology ; Leptin ; Risk Factors ; Adipokines
Czasopismo naukowe
Tytuł:
Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.
Autorzy:
Bwanika HC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Leo IR; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Struyf N; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Talanti A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Aswad L; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Konnur A; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Björklund AC; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Huddinge, Sweden.
Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Rassidakis G; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.
Erkers T; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Seashore-Ludlow B; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Jafari R; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden.; Science for Life Laboratory, Solna, Sweden.
Pokrovskaja Tamm K; Department of Oncology and Pathology, Karolinska Institutet, Akademiska stråket 1, BioClinicum J6:14, 17164, Solna, Sweden. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 18; Vol. 14 (1), pp. 4000. Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Autophagy ; Cell Line ; Glucocorticoids/therapeutic use ; Cell Line, Tumor ; Apoptosis
Czasopismo naukowe
Tytuł:
COVID-19 in Pediatric Patients With Acute Lymphoblastic Leukemia or Lymphoma.
Autorzy:
Hashmi SK; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
Bodea J; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Patni T; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
Angel S; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Bhakta NH; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
Jeha S; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
Karol SE; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Ribeiro RC; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Rubnitz JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Wolf J; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.
Li Y; Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
Pui CH; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.; Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
Hijano DR; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.
Inaba H; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee.
Pokaż więcej
Źródło:
JAMA network open [JAMA Netw Open] 2024 Feb 05; Vol. 7 (2), pp. e2355727. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/complications
COVID-19*/epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/epidemiology
Lymphoma*/complications
Lymphoma*/epidemiology
Humans ; Male ; Child ; Child, Preschool ; Adolescent ; Female ; SARS-CoV-2 ; Retrospective Studies ; COVID-19 Testing ; Reinfection
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report.
Autorzy:
Dong Q; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Darwish T; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Howard M; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Shetty S; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Wang Y; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Xiu Y; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Gallogly M; Department of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Zhao C; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.; Department of Pathology, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Pokaż więcej
Źródło:
The Journal of international medical research [J Int Med Res] 2024 Feb; Vol. 52 (2), pp. 3000605231156757.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Humans ; T-Lymphocytes ; Philadelphia Chromosome
Czasopismo naukowe
Tytuł:
Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Autorzy:
Barone T; Department of Pharmacy, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Dandekar S; Division of Pediatric Hematology/Oncology, Penn State Children's Hospital, Hershey, Pennsylvania, USA.
McKeone D; Division of Pediatric Hematology/Oncology, Penn State Children's Hospital, Hershey, Pennsylvania, USA.
Mulieri K; Department of Pharmacy, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Pokaż więcej
Źródło:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Feb; Vol. 7 (2), pp. e1987.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Hypoglycemia*/drug therapy
Drug-Related Side Effects and Adverse Reactions*
Chemical and Drug Induced Liver Injury*/drug therapy
Lymphoma*/diagnosis
Lymphoma*/drug therapy
Pancreatitis*/chemically induced
Pancreatitis*/diagnosis
Humans ; Child ; Mercaptopurine/adverse effects ; Allopurinol/adverse effects
Czasopismo naukowe
Tytuł:
Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report.
Autorzy:
Arahirwa V; University of North Carolina School of Medicine, Chapel Hill, USA. victor_.
Thahir S; University of North Carolina School of Medicine, Chapel Hill, USA.
Hernandez L; University of North Carolina School of Medicine, Chapel Hill, USA.
Willis ZI; University of North Carolina School of Medicine, Chapel Hill, USA.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 154. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Nocardia*
Nocardia Infections*/diagnosis
Nocardia Infections*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Male ; Child ; Humans ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; Anti-Bacterial Agents/therapeutic use
SCR Organism:
Nocardia nova
Czasopismo naukowe
Tytuł:
Abnormal bone marrow T1-weighted MRI images in a pediatric patient with acute lymphoblastic leukemia without peripheral blasts.
Autorzy:
Oyake M; Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka, Yufu, Oita, 879-5593, Japan.
Hirakuni Y; Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka, Yufu, Oita, 879-5593, Japan.
Hirano N; Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka, Yufu, Oita, 879-5593, Japan.
Suenobu S; Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka, Yufu, Oita, 879-5593, Japan. .; Division of General Pediatrics and Emergency Medicine, Oita University Faculty of Medicine, Yufu, Oita, 879-5593, Japan. .
Ihara K; Department of Pediatrics, Oita University Faculty of Medicine, 1-1 Idaigaoka, Yufu, Oita, 879-5593, Japan.
Pokaż więcej
Źródło:
International journal of hematology [Int J Hematol] 2024 Feb; Vol. 119 (2), pp. 107-108. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Letter
MeSH Terms:
Bone Marrow*/diagnostic imaging
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnostic imaging
Humans ; Child ; Leukocytes ; Magnetic Resonance Imaging
Opinia redakcyjna
Tytuł:
Novel Biomarkers and Molecular Targets in ALL.
Autorzy:
De Sa H; OHSU Center for Health and Healing, Oregon Health & Science University, 3485 S Bond Ave, Mail Code OC14HO, Portland, OR, 97239, USA.
Leonard J; OHSU Center for Health and Healing, Oregon Health & Science University, 3485 S Bond Ave, Mail Code OC14HO, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Current hematologic malignancy reports [Curr Hematol Malig Rep] 2024 Feb; Vol. 19 (1), pp. 18-34. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Leukemia, Myeloid, Acute*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adult ; Child ; Humans ; Prognosis ; Mutation ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Relapsed/Refractory T- Acute Lymphoblastic Leukemia - Current Options and Future Directions.
Autorzy:
Jeha S; Departments of Global Pediatric Medicine and Oncology, St. Jude Children's Research Hospital, Memphis, TN, 38103, USA. .
Pokaż więcej
Źródło:
Indian journal of pediatrics [Indian J Pediatr] 2024 Feb; Vol. 91 (2), pp. 168-175. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Humans ; Child ; Prognosis ; Immunotherapy
Czasopismo naukowe
Tytuł:
Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.
Autorzy:
Zhou Y; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.; Shandong University, Jinan, 250100, Shandong Province, China.
He H; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.; Shandong University, Jinan, 250100, Shandong Province, China.
Ding L; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.; Shandong University, Jinan, 250100, Shandong Province, China.
Wang T; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.; Shandong University, Jinan, 250100, Shandong Province, China.
Liu X; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.; Shandong University, Jinan, 250100, Shandong Province, China.
Zhang M; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.; Shandong University, Jinan, 250100, Shandong Province, China.
Zhang A; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China. .; Shandong University, Jinan, 250100, Shandong Province, China. .
Fu J; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China. .; Shandong University, Jinan, 250100, Shandong Province, China. .
Pokaż więcej
Źródło:
European journal of pediatrics [Eur J Pediatr] 2024 Feb; Vol. 183 (2), pp. 581-590. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Methotrexate*/adverse effects
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Child ; Humans ; Polymorphism, Genetic ; Genotype ; Methylenetetrahydrofolate Reductase (NADPH2)/genetics ; Phenylalanine ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome-positive acute lymphoblastic leukemia: two-case report.
Autorzy:
Fan S; Hematology Department, the First Hospital of Lanzhou University, Lanzhou City, Gansu Province, China. .
Wang L; Hematology Department, the First Hospital of Lanzhou University, Lanzhou City, Gansu Province, China.
Lu Y; The First Clinical Medical College, Lanzhou University, Lanzhou City, Gansu Province, China.
Li Z; Hematology Department, the First Hospital of Lanzhou University, Lanzhou City, Gansu Province, China.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Feb; Vol. 103 (2), pp. 525-532. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Philadelphia Chromosome*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Piperidines*
Antibodies, Bispecific*
Pyrazoles*
Benzamides*
Alkynes*
Pyridines*
Humans ; Drug Resistance, Neoplasm/genetics ; Protein Kinase Inhibitors/therapeutic use ; Fusion Proteins, bcr-abl/genetics ; Mutation
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies